Table 1 Effects of test agents on baseline MSAP, HR and power density of vasomotor components of SAP spectrum
Treatment | Maximal changes in | ||
|---|---|---|---|
MSAP (mmHg) | HR (bpm) | Power Density (mmHg2) | |
aCSF | +3.3 ± 0.4 | +4.9 ± 0.6 | +0.7 ± 0.5 |
ICI 182780 (0.25 pmol) | +3.3 ± 0.6 | +5.5 ± 0.8 | +0.7 ± 0.5 |
ICI 182780 (0.5 pmol) | +2.5 ± 0.5 | +3.5 ± 0.8 | +0.6 ± 0.6 |
R,R-THC (50 pmol) | +6.4 ± 0.6 | +6.5 ± 1.0 | +0.8 ± 0.4 |
MPP (1 nmol) | +6.1 ± 0.8 | +6.6 ± 0.8 | +0.9 ± 0.7 |
L-NAME (5 nmol) | +3.8 ± 0.6 | +5.6 ± 0.6 | +0.9 ± 0.6 |
SMT (25 pmol) | +3.7 ± 0.8 | +5.3 ± 0.8 | +0.7 ± 0.5 |
7-NI (0.5 pmol) | -2.7 ± 0.8 | -3.3 ± 0.5 | -0.6 ± 0.8 |
L-NIO (2.5 pmol) | -1.9 ± 0.8 | -3.6 ± 0.7 | -1.0 ± 0.6 |